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Sulfotransferase-Mediated Chlorination of
1-Hydroxymethylpyrene to a Mutagen
Capable of Penetrating Indicator Cells
by Hansruedi Glatt,* Reinhard Henschler,* David H.
Phillips,t Jerry W. Blake,* Pablo Steinberg,* Albrecht
Seidel,* and Franz Oesch*
Methylated polycyclic aromatic hydrocarbons are common in the human environment. Many of them
are stronger carcinogens than their purely aromatic congeners. They may be metabolized to benzylic
alcohols. We report here on biochemical and toxicological characteristics of 1-hydroxymethylpyrene
(HMP), a typical representative ofthis class ofcompounds. Rat liver cytosol, fortified with 3'-phosphoad-
enosine-5'-phosphosulfate, converted HMP into its sulfate ester (HMPS). HMPS bound covalently to
isolated DNA. In physiological buffer at 370C, HMPS had a half-life of 2 min, the major decomposition
product being HMP. Thus, cyclic activation is possible. When Cl- anions were present at physiological
concentrations, anadditionalreactionproductofHMPS, 1-chloromethylpyrene (CIMP), couldbeidentified
on the basis of its chromatographic properties and its mass spectrum, using the authentic standard for
comparison. CIMP was shorter-lived in buffer than HMPS. CIMP reacted with DNA, the adduct pattern
in the 32P-postlabeling analysis being similar, or identical, to that of HMPS. CIMP proved to be a very
potent mutagen in Salmonella typhimurium, whereas HMPS, and HMP in the presence of a sulfate-
conjugating system, showed strong mutagenicity only when Cl- or Br- ions were present in the exposure
buffer. It is concluded that HMPS is capable of reacting with DNA, but is hampered in its distribution
by membrane barriers. Strikingly, a CIMP intermediate is produced, which can act as a transport form
to overcome membrane barriers. Among 10 investigated tissues, HMP-activating sulfotransferases were
found at appreciable levels only in the liver, and there the activity in parenchymal cells exceeded that in
Kupffercellsby afactorof - 200. Distributionprocessesandtheirrestrictions may, therefore, be important
factorsdeterminingthetoxicologyofbenzylicalcoholsandothercompounds activatedthroughconjugation
with sulfate.
Introduction
Short-term tests have become a major tool in the de-
tection of carcinogens and mutagens. In these systems,
the active chemical species is frequently formed outside
the indicator cell. If cell membranes act as barriers for a
particular species, the result may be negative despite in-
trinsic reactivity toward important cell structures. Met-
abolic formation of such species within particular cells in
the organism may produce tissue-specific toxicological ef-
fects. Difficulties in the penetration of membranes may
be expected to exist, particularly with ionized chemical
species such as sulfate conjugates.
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Strong evidence has accumulated that sulfate conju-
gates play a major role in some carcinogenic effects of
aromatic amines andalkenylbenzenes (1). Strikingly, how-
ever, the addition ofa sulfate-conjugating system usually
decreased the mutagenicity ofaromatic amines and their
metabolites in Salmwnella typhimurium, whereas the
covalent binding to isolated nucleic acids was enhanced
(2-4). On the other hand, Watabe et al. (5-7) have ob-
served DNA binding as well as bacterial mutagenicity for
benzylic sulfate esters and alcohols, the latter requiring
the presence of a sulfotransferase-containing metabolic
system. To study structural and metabolic parameters
governingthismutagenicity, wehave synthesized aseries
of benzylic alcohols and sulfate esters. The exceedingly
unusual characteristics that we have detected are de-
scribed here for a representative benzylic alcohol, 1-hy-
droxymethylpyrene (HMP), and its sulfate ester, HMPS.
This pair of compounds is of special interest, since the
carbonium ion that results from heterolytic cleavage of
the ester is stabilized by the same aromatic system as theGLATT ET AL.
carbonium ion formed from the bay-region diol-epoxide of
benzo(a)pyrene, the most thoroughly investigated active
metabolite of a polycycic aromatic hydrocarbon.
The peculiarities of this mutagenicity include the oc-
currence of a cyclic activation process and the formation
ofamembrane-penetrating halogenated intermediate (the
sulfate ester itselfbeing practically incapable of entering
the target cell). Furthermore, it has been found that the
sulfotransferases which activate HMP occur only in few
tissues, in particular in the liver, where they are further
confined to certain cell types. Transport processes and
their restrictions therefore appear to be essential factors
in the toxicology ofthis class of compounds.
Materials and Methods
Chemicals
1-Pyrene carboxaldehyde was supplied by Aldrich
Chemical Company (Steinheim, FRG). HMP was pre-
pared from 1-pyrene carboxaldehyde by reduction with
sodium borohydride in methanol. The product was puri-
fied by flash chromatography and finally recrystallized
from n-hexane. HMPS was synthesized by sulfatation of
HMP as described by Watabe et al. (5). Heating ofHMP
in the presence of thionyl chloride produced 1-chlorome-
thylpyrene (CIMP). Treatment ofthe crude product with
n-hexane fur-nished pure CIMP. 3'-phosphoadenosine-5'-
phosphosulfate (PAPS) was purchased from Pharmnacia
LKB GmbH (Freiburg, FRG).
Subcellular Preparations
Unless otherwise indicated, adult male Sprague-Daw-
ley rats, not treated with an enzyme inducer, were used.
Tissues were homogenized in three volumes of ice-cold
buffer B (150 mM KCI, 10 mM sodium phosphate buffer,
pH 7.4), usingan Elvejhemglass/teflon homogenizer. The
supernatant (S9) of a 9000g centrifugate (10 min) was
separated into microsomal and cytosolic fractions by cen-
trifugation at 100,000g for 1 hr. Cytosol was dialyzed for
3 hr against buffer B.
Separation of Liver Cell Types
Liver parenchymal cells were isolated using a two-step
collagenase perfusion method (8). Nonparenchymal cell
suspensions were prepared as described elsewhere (9).
Endothelial and Kupffer cells were purified from nonpar-
enchymal cell suspensions by centrifugal elutriation (10).
Endothelial and Kupffer cell preparations contained <
0.5% parenchymal cells, whereas the parenchymal cell
preparations contained < 5% nonparenchymal cells.
Mutagenicity Assay
The his- Salwmella typhimurium strain TA98 was
grownandresuspended inmediumA(1.6gBactonutrient
broth and 5 g NaCl/L) as described previously (11). In
the direct test, buffer B (500 ,uL), bacterial resuspension
(100 ,uL), and the test compound (added in 10 ,iL di-
methylsulfoxide) were mixedinaglasstubeandincubated
for 20 min at 37°C. Then, 2 mL of 45°C warm soft agar
(0.55% agar, 0.55% NaCl, 50 ,uM histidine, 50 ,uM biotin,
25 mM sodium phosphate buffer, pH 7.4) was added, and
the mixture was poured onto a Petri dish containing 24
mL minimal agar (1.5% agar in Vogel-Bonner E medium
with 2% glucose). After incubation for 3 days in the dark,
colonies (his' revertants) were counted.
In the experiments in which the stability of mutagens
in the incubation buffer was studied, the assay was mod-
ified in that the bacteria were added to the buffer 0 to 20
min after the addition ofthe test compounds (12).
In the enzyme-mediated test, the procedure was as
above, but buffer B was replaced in part by cytosol (167
ILL in the standard assay; variable amounts in the com-
parison of cytosols from different tissues) and cofactor
solution (10 mM ATP, 10 mM Na2SO4, 6 mM MgCl2 in
the total incubation volume, 610 ,uL). In some cases, ATP
was replaced by PAPS (5-100 ,M).
The compounds (Table 1) or the enzyme preparations
(Table 2) were tested at 5 to 15 concentrations, usually
with 3 incubations for each treatment group. Revertants
per nanomole test compound (specific mutagenicities) and
revertants per milligram protein of the enzyme prepa-
ration were calculated from the increasing part of the
concentration-response curve as described previously
(11).
32P-Postlabeling Analysis
The test compound (at concentrations of0.1, 1, and 10
,uImL) wasincubated at37°C inbufferB or 10mM sodium
phosphate buffer (pH 7.4), as described for the mutagen-
icity assay, except that the bacteria were replaced by
salmon sperm DNA (10 ,ug/mL). The DNA was then iso-
lated, digested and 32P-postlabeled, and the nucleotides
were chromatographically separated as described previ-
ously (12).
Identification of Products Formed from
HMPS in Buffer
HMPS (1.2 mM) was incubated in buffer B or H20 for
20 min (equivalent to 10 half-lives). The incubate (1 mL)
was then extracted twice with an equal volume of ethyl
acetate. The extract was dried over Na2SO4 and the sol-
vent evaporated. The residue was chromatographed on
silica-gel thin layer plates using a mixture ofchloroform/
methanol (19:1; v/v); HMPS, HMP, and 1-pyrene carbox-
aldehyde were used as reference compounds.
In a second experiment, a continuous extraction ofthe
incubate withn-hexane wasperformedfor20min(10half-
lives) starting immediately after the addition of the test
compound. After drying over Na2SO4 the extract was
concentrated, and an aliquot was analyzed by gas chro-
matography-mass spectrometry (GC-MS). GC-MS was
perforned on a Finnigan MAT model Incos5O quadrupole
mass spectrometer (EI mode; 70 eV)/gas chromatograph
(Varian 3400) interfaced to an INCOS data system. The
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Table 1. Mutagenicity in Salmonella typhimurium TA98 of 1-hydroxymethylpyrene and derivatives under various
experimental conditions.
Compound
1-Hydroxymethylpyrene
Exposure mediuma
KCI, 125 mM; Na phosphate buffer, pH 7.4, 8 mMc
Postmitochondrial fraction, NADPHd
Cytosol, PAPS
Cytosol, ATP
Cytosol, no cofactor
PAPS, no cytosol
ATP, no cytosol
Cytosol, ATP, no chloride
Specific mutagenicity,
revertants/nmoleb
< 0.01
9
970e
770,f 900, 1160e
< 0.1
< 0.1
< 0.1
30e,g
1-Hydroxymethylpyrene sulfate KC1, 125 mM; Na phosphate buffer, pH 7.4, 8 mMc 250, 530, 450
H20 80; ioe
KCI 250 mM 760; 360'
KCI 125 mM 760; 540e
KCI 62 mM 610; 370'
KCI 31 mM 290; 190'
NaCl 125 mM 470; 180e
MgCl2 62 mM 180; goe
K2SO4 62 mM ise
K acetate 125 mM 80e
K phosphate buffer, pH 7.4, 62 mM 13e
Na2SO4 62 mM 56
Na phosphate buffer, pH 7.4, 80 mM 35
Glucose 250 mM 56
1-Pyrene carboxaldehyde KCl, 125 mM; Na phosphate buffer, pH 7.4, 8 mMC < 0.1
1-Chloromethylpyrene KC1, 125 mM; Na phosphate buffer, pH 7.4, 8 mMc 46,000; 31,000
aUnless indicated otherwise, bacteria were added in resuspension medium, adding 14 mM NaCl (final concentration) and Bacto nutrient
broth (0.25 mg/mL) to the exposure medium.
bEach value represents a separate experiment. For negative results, detection limits are given. Differences in the detection limits may be
because the maximal concentrations used were different.
'Buffer B, corrected for the dilution by bacterial suspension and solution of test compound.
dClassical S9 mix, prepared from liver of Aroclor 1254-treated Sprague-Dawley rat, was used. Exactly the same protocol as in a previous
study (12) was used.
eThe bacteria were resuspended in distilled water.
'A Wistar rat was used.
gIsotonic sucrose solution was used as the homogenization buffer. MgCl2 and KC1 were replaced by MgSO4 and potassium phosphate (pH
7.4) buffer, respectively.
sample in n-hexane was injected in the splitless mode,
with the injector temperature at 210°C, onto a 15-m DB-
1 capillary column with 0.25 mm internal diameter (5%
methyl silicone as liquid phase), with helium as the carrier
gas (flow rate: 3 mL/min) and eluted with a temperature
gradient (20°C/min) from 70°C to 260°C.
Results
Mutagenicity in Salmonella typhimurium
TA98
HMP and its oxidation product, 1-pyrene carboxalde-
hyde, were not mutagenic in the direct test. However,
when NADPH-fortified postmitochondrial fraction from
the liver of Aroclor 1254-treated rats (the classical acti-
vating system of the Ames test) or PAPS-fortified rat
liver cytosol was added, the number ofmutants per plate
was increased about 100-fold above background (from 30
to about3000colonies) atoptimal dose ofHMP. The initial
part ofthe dose-response curves was slightly hyperlinear,
whereas at high doses mutagenicity was overshadowed
by bacteriotoxicity. For the induction of equal effects,
about 100 times higher concentrations of HMP were re-
quired with postmitochondrial fraction and NADPH than
with cytosol and PAPS, resulting in corresponding dif-
ferences in the specific mutagenicity (Table 1). Due to the
high cost ofPAPS, it was usually replaced by ATP, serv-
ing as substrate for the in situ generation ofPAPS in the
system used. Similar mutagenicities were observed with
these cofactors (except when the cytosol was used at lim-
iting concentrations). Cytosol in the absence of cofactor
and PAPS and ATP in the absence of cytosol were fully
devoid of any activating effect on HMP. These observa-
tions strongly suggested the involvement of sulfotrans-
ferases.
Authentic HMPS showed directmutagenic activity, the
maximal effect and the shape of the concentration-re-
sponse curve being similar to that of bioactivated HMP.
It was somewhatsurprisingthat the specific mutagenicity
of HMPS only amounted to about one-third of that of
metabolically activated HMP (Table 1) and was further
reduced in the presence of cofactor-free cytosol. On the
other hand, fortification ofthe cytosol with ATP resulted
in a 3-fold enhancement of the mutagenicity of HMPS
(data not shown). This suggests that not only HMP, but
also HMPS or ametabolite(s), are subjected to sulfotrans-
ferase-mediated activation.
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Table 2. Activation of 1-hydroxymethylpyrene by cytosol from
various tissues and cells from Sprague-Dawley rats.a
Revertants/mg
Tissue, cell Cofactor tissue equivalentb
Preparations from males
Liver ATP 1240; 1370; 1770; 2100
Parenchymal cells ATP 1080b
Kupffer cells ATP 5b
Endothelial cells ATP 200b
Lung ATP < 0.3
Small intestine ATP < 0.3
Spleen ATP < 0.3
Adrenal gland ATP < 1
Heart ATP < 0.3
Brain ATP < 0.3
Testis ATP 4; 10
Preparations from females
Liver ATP 2480
Liver PAPS 10,000
Kidney PAPS 115
Lung PAPS < 0.3
Small intestine PAPS < 0.3
Adrenal glandc PAPS 2.7
Heart PAPS 0.7
Mammaryc PAPS 1.5
'A constant dose of test compound (10 ,ug) was incubated with
various concentrations of dialyzed cytosol in the presence of 10 mM
ATP (which should give rise to the formation of PAPS under the
experimental conditions) or of 5 ,uM PAPS. After subtraction ofthe
background value, the number ofmutants was divided by the amount
of cytosol added. Multiple values represent experiments carried out
on separate occasions. For negative results the detection limit is
shown.
bResults for thedifferent liver cell types are expressed per 100 ,ug
cytosolic protein.
ePostmitochondrial fraction instead of purified cytosol was used.
It was conspicuous that the mutagenicity of HMPS
was strongly dependent on the composition of the ex-
posure medium, especially on the presence and the na-
ture of anions (Table 1). In the absence of chloride,
bromide, and acetate anions, the mutagenicity was re-
duced to 2% ofthat under standard conditions in which
chloride was present at aconcentration of139mM. Bro-
mide and, with lower efficiency, acetate, could substi-
tute for chloride, whereas sulfate and phosphate were
without effect. The influence of cations was much less
than that of anions. In all exposure media used, the
mutagenicity of the positive control, benzo(a)pyrene
4,5-oxide, varied only within a factor of 2.5 (data not
shown), which excludes nonspecific mechanisms, such
as bacteriotoxicity ofmedium constituents, for the dif-
ferences observed with HMPS. Replacement of the
chloride ions not only reduced the mutagenicity of
HMPS, but also that ofbioactivated HMP (Table 1).
CIMP turned out to be an extremely potent, direct-
acting mutagen in Salmonella typhimurium (Table 1).
Its potency exceeded those of all investigated diol-epox-
ides and other metabolites of polycycic aromatic hydro-
carbons (13). Under our standard conditions (buffer B),
CIMP was about 100 times more active than HMPS, the
difference being even larger in chloride-free medium.
Stability in the Exposure Medium
The stabilities were determined fromthe decline in mu-
tagenicity afterpreincubation ofthe test compound in the
absence ofthe bacteria for varying times. In buffer B at
37°C, the decline in mutagenicity ofHMPS followed first-
orderkinetics, with a half-life of2 min. The same kinetics
were observed in distilled water, within the limits of ac-
curacy resulting from the low mutagenicity under these
conditions. CIMP was less stable than HMPS. Preincu-
bation for 20 sec in buffer B resulted in a more than 50%
decrease in mutagenicity.
Identification of the Products Formed
from HMPS in Buffer
HMPSwasincubated for 10half-livesinbufferB. After
this time, virtually all material with pyrenelike chrom-
ophores was extractable. Thin-layer chromatography of
the extract showed two spots with the Rfvalues ofHMP
and 1-pyrene carboxaldehyde. When HMP was subjected
to the same incubation and extraction procedure, the al-
dehyde was formed as well, indicating a significant au-
toxidation of HMP.
In a second experiment, extraction was started simul-
taneously with the addition of HMPS. In this case, the
thin-layer chromatogram showed a third spot with the Rf
value of CIMP. The extract was then analyzed by GC-
MS. A peak was found which had the retention time and
the mass spectrum of CIMP (Fig. 1). The molecular ions
were observed at 250 and 252 m/z with the characteristic
3:1 ratio, correspondingtothenaturalisotope distribution
ofchlorine. The base peak, at 215 m/z, corresponds to the
benzylic carbonium ion.
32P-Postlabeling Analysis of DNA
Incubated with HMPS and CIMP
Both HMPSand CIMPfonnedadductswhentheywere
incubatedwithsalmonsperm DNAinchloride-freebuffer.
The two adduct patterns, resolved by four-dimensional
thin-layer chromatography, consisted offour major spots
and were indistinguishable. The adduct level was, how-
ever, higher for CIMP. Addition of KCI (150 mM) to the
reaction mixture did not affect adduct level and pattern
ofeither compound.
Tissue and Cell Distribution of HMP-
Activating Sulfotransferases
Among seven investigated extrahepatic tissues ofmale
rats, onlyATP-fortifiedcytosolfromtestisactivated HMP
to a mutagen (Table 2). The amount oftestis protein re-
quired for induction ofan equal effect was more than 100
times higher than for liver. Among different liver cell
types, the parenchymal cells showed the highest levels of
activity. Substantial levels were present in endothelial
cells as well, whereas those in Kupffer cells were very
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FIGURE 1. Mass spectra of a metabolite extracted from an incuba-
tion of 1-hydroxymethylpyrene sulfate in buffer B (150 mM KCl,
20 mM sodium phosphate buffer, pH 7.4) (upper panel) and au-
thentic 1-chloromethylpyrene (lower panel).
low and might result from low-level contamination ofthe
preparation with other cells.
Hepatic cytosol from female rats appeared to be about
twice as active as preparations from males. When cytosol
was used at limiting concentrations (in contrast to sub-
strate-limited situations) PAPS was superior to ATP as
the cofactor. Using PAPS, HMP-activating activity could
be demonstrated in several extrahepatic tissues offemale
rats. However, the levels were
- 1% ofthat found in the
liver.
Discussion
Biotransformation of HMP to Mutagenic
Species
HMP was activated to mutagens by at least two dif-
ferentmetabolic routes. The firstpathway occurred in the
presence of the postmitochondrial fraction and NADPH
and probably involved microsomal oxidative metabolism.
The second pathway, yielding much higher mutagenicity,
required the presence of cytosol and PAPS (or its pre-
cursor, ATP). Authentic HMPS proved to be chemically
reactive. It reacted with water and other nucleophiles
including DNA and halogen anions.
Reaction of HMPS with water led to the fonnation of
HMP, themetabolicprecursorofHMPS. Cyclicactivation
therefore appears possible. This idea was supported by
the observations that HMPin the presence ofcytosol and
ATP was more mutagenic than HMPS in the absence of
a hepatic metabolizing system and that the mutagenicity
of HMPS in the presence of cytosol was increased on
addition of ATP. The mutagenicity results indicated the
occurrence ofabout three rounds ofactivation under our
experimental conditions. Cyclic metabolism not only en-
hances the risk of reaction with important tissue mole-
cules, it also should lead to waste ofenergy through con-
version ofactive sulfate (PAPS) to inorganic sulfate.
HMPS reacted with DNA and appeared to forn the
same adducts as did the strong mutagen, CIMP. Never-
theless, HMPS was only very weakly mutagenic, unless
chloride anions or similar nucleophiles were added to the
medium. These findings suggest that extracellularly gen-
erated HMPS itselfhas little or no access to the bacterial
DNA. It is probable that the cell membrane acts as a
barrier for the ionized sulfate ester and the potentially
formed benzylic carbonium ion.
Fornation of CIMP was observed on incubation of
HMPS in chloride-containing buffer. CIMP was highly
unstable in water, reacted with DNA, and proved to be
an extraordinarily potent mutagen in Salmwnella typhi-
murium. The strongly potentiating influence of chloride
anions on the mutagenicity ofHMPS indicated thatCIMP
probably acted as the transport form of the mutagen.
Calculation of the specific mutagenicities of HMPS and
CIMP in the presence ofchloride (buffer B) and ofHMPS
in chloride-free buffer indicates that about 1% of HMPS
was converted to CIMP. Although this amount may be
considered small, it was ofgreat toxicological significance
in the assay. Since the chloride concentration, pH, and
temperature used were in the physiological range, this
reaction may also occur in vivo. At least the cytosol-me-
diated activation ofHMP was dependent on the presence
of chloride anions, demonstrating that liver enzymes do
not prevent the reaction.
The finding that cytosol-mediated activation ofHMP is
dependent onthepresence ofchloride anions indicates the
occurrence of a metabolic halogenation of HMP. To our
knowledge this is the first observed case of metabolic
chlorination of a xenobiotic in a mammalan enzyme sys-
tem.
The strong effect ofhalogen anions onthemutagenicity
of HMPS was unexpected and observed accidentally. It
demonstrates that apparently unimportant details ofthe
protocolmayhave aprofoundinfluenceonthetestresults.
Unfortunately, many authors reporting short-term tests
do not describe their method in detail, but only refer to
47
.1148 GLATT ET AL.
review papers, not allowing reconstruction of the exact
protocol. Thus, their results may not be reproducible by
others and sometimes not even interpretable.
Toxicological Implications of Hampered
Transport ofActive Species
A number of compounds are known that are activated
through conjugation with sulfate to their ultimate carcin-
ogenic and genotoxic metabolites (1). To our knowledge,
benzylic alcohols are the only group for which a positive
result has been obtained in a short-term test using an
exogenous sulfate-conjugating system for the activation
(5-7). Inthe present study, itwas demonstrated that this
effect involves a special mechanism, namely, substitution
of the polar sulfate group by a nonpolar halogen group.
When this substitution was not possible, HMPS reacted
with free DNA, but was only a poor mutagen, apparently
because of problems in entering the indicator cell. It is
reasonable to assume that not all reactive sulfate conju-
gates may be converted into a transport form. Their tox-
icological effects therefore may be restricted to the cell
where they are formed, and possibly even some of its
compartments. And since sulfotransferases, as shown
here forthe HMP-activatingenzymes, are present at high
levels in only few cell types in the organism, high target
tissue selectivity mayresult. Thisimplies that effects may
be absent in common target tissues used in in'uivo short-
tenn tests, such as bone marrow and skin. The likelihood
is also high that false negative results occur in tests with
bacteria and cells in culture using exogenous activating
systems. Taldng into account the difficulties in detection,
very little is known about how maniy chemicals are acti-
vated to reactive sulfates and, in general, to active me-
tabolites incapable ofpenetrating membranes.
Perspectives
The barrier problem requires a special approach for
the detection ofsulfotransferase-mediated toxicological
effects. The first possibility is offered by cell-free sys-
tems, using, for example, binding to free DNA as the
end point. The alternative is sulfotransferase-express-
ing indicator cells, in particular freshly isolated hepa-
tocytes. The involvement of sulfotransferases may be
examined by comparing the effect in control and cofac-
tor-depleted cells. The most relevant end points with
regard to genotoxicity can be studied only in prolifer-
ating cells and therefore hepatocytes are not suitable.
Recently, cytochromes P-450 were introduced and per-
manently expressed in V79 cells through gene transfer
(14,15). Various compounds have proved to be muta-
genic in these cells butinactive in parent V79 cells. The
same approach is being used for sulfotransferases. A
1.0kbpcDNAfragmentofaHMP-activatingsulfotrans-
ferase has been cloned and is being used in the search
for a full-length cDNA clone. Pairs ofsulfotransferase-
expressing and nonexpressing cell lines should provide
further insight into the role ofthis enzyme in metabolic
toxification and into barriers affecting the toxic effects.
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